YKL-40: a Candidate Biomarker for Simian Immunodeficiency Virus and Human Immunodeficiency Virus Encephalitis?

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 2008 Jun 28

PMID 18583323

Citations 5

Authors

Dennis L Kolson

Affiliations

Soon will be listed here.

Citing Articles

Inflammatory Effects and Regulatory Mechanisms of Chitinase-3-like-1 in Multiple Human Body Systems: A Comprehensive Review.

Liu D, Hu X, Ding X, Li M, Ding L Int J Mol Sci. 2025; 25(24.

PMID: 39769202 PMC: 11678640. DOI: 10.3390/ijms252413437.

Advances in SIV/SHIV Non-Human Primate Models of NeuroAIDS.

Moretti S, Virtuoso S, Sernicola L, Farcomeni S, Maggiorella M, Borsetti A Pathogens. 2021; 10(8).

PMID: 34451482 PMC: 8398602. DOI: 10.3390/pathogens10081018.

Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection.

Hermansson L, Yilmaz A, Axelsson M, Blennow K, Fuchs D, Hagberg L J Neuroinflammation. 2019; 16(1):16.

PMID: 30678707 PMC: 6345016. DOI: 10.1186/s12974-019-1404-9.

HIV/neuroAIDS biomarkers.

Rahimian P, He J Prog Neurobiol. 2016; 157:117-132.

PMID: 27084354 PMC: 5705228. DOI: 10.1016/j.pneurobio.2016.04.003.

Cerebrospinal Fluid Biomarkers of Simian Immunodeficiency Virus Encephalitis : CSF Biomarkers of SIV Encephalitis.

Bissel S, Kofler J, Nyaundi J, Murphey-Corb M, Wisniewski S, Wiley C J Neuroimmune Pharmacol. 2016; 11(2):332-47.

PMID: 27059917 PMC: 4871628. DOI: 10.1007/s11481-016-9666-9.

References

GOLD L, Fox H, Henriksen S, Buchmeier M, Weed M, Taffe M . Longitudinal analysis of behavioral, neurophysiological, viral and immunological effects of SIV infection in rhesus monkeys. J Med Primatol. 1998; 27(2-3):104-12. DOI: 10.1111/j.1600-0684.1998.tb00234.x. View

Brew B, Gonzalez-Scarano F . HIV-associated dementia: an inconvenient truth. Neurology. 2007; 68(5):324-5. DOI: 10.1212/01.wnl.0000252803.24176.76. View

Chang L, Ernst T, Witt M, Speck O, Walot I, Miller E . Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology. 1999; 53(4):782-9. DOI: 10.1212/wnl.53.4.782. View

Dunfee R, Thomas E, Gorry P, Wang J, Taylor J, Kunstman K . The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia. Proc Natl Acad Sci U S A. 2006; 103(41):15160-5. PMC: 1586182. DOI: 10.1073/pnas.0605513103. View

Bandaru V, McArthur J, Sacktor N, Cutler R, KNAPP E, Mattson M . Associative and predictive biomarkers of dementia in HIV-1-infected patients. Neurology. 2007; 68(18):1481-7. PMC: 4431621. DOI: 10.1212/01.wnl.0000260610.79853.47. View

Heyes M, Brew B, Martin A, Price R, Salazar A, Sidtis J . Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol. 1991; 29(2):202-9. DOI: 10.1002/ana.410290215. View

Johansen J, Jensen B, Roslind A, Nielsen D, Price P . Serum YKL-40, a new prognostic biomarker in cancer patients?. Cancer Epidemiol Biomarkers Prev. 2006; 15(2):194-202. DOI: 10.1158/1055-9965.EPI-05-0011. View

Dono R . Fibroblast growth factors as regulators of central nervous system development and function. Am J Physiol Regul Integr Comp Physiol. 2003; 284(4):R867-81. DOI: 10.1152/ajpregu.00533.2002. View

Brew B, Pemberton L, Blennow K, Wallin A, Hagberg L . CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology. 2005; 65(9):1490-2. DOI: 10.1212/01.wnl.0000183293.95787.b7. View

10.

. UNAIDS/WHO report highlights epidemic resurgence. AIDS Alert. 2007; 22(1):suppl 1-3. View

11.

Mankowski J, Clements J, Zink M . Searching for clues: tracking the pathogenesis of human immunodeficiency virus central nervous system disease by use of an accelerated, consistent simian immunodeficiency virus macaque model. J Infect Dis. 2002; 186 Suppl 2:S199-208. DOI: 10.1086/344938. View

12.

Bissel S, Wang G, Trichel A, Murphey-Corb M, Wiley C . Longitudinal analysis of monocyte/macrophage infection in simian immunodeficiency virus-infected, CD8+ T-cell-depleted macaques that develop lentiviral encephalitis. Am J Pathol. 2006; 168(5):1553-69. PMC: 1457021. DOI: 10.2353/ajpath.2006.050240. View

13.

Towfighi A, Skolasky R, St Hillaire C, Conant K, McArthur J . CSF soluble Fas correlates with the severity of HIV-associated dementia. Neurology. 2004; 62(4):654-6. DOI: 10.1212/01.wnl.0000110188.37546.51. View

14.

Ryan L, Zheng J, BRESTER M, Bohac D, Hahn F, Anderson J . Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection. J Infect Dis. 2001; 184(6):699-706. DOI: 10.1086/323036. View

15.

Eugenin E, Osiecki K, Lopez L, Goldstein H, Calderon T, Berman J . CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J Neurosci. 2006; 26(4):1098-106. PMC: 6674577. DOI: 10.1523/JNEUROSCI.3863-05.2006. View

16.

Antinori A, Arendt G, Becker J, Brew B, Byrd D, Cherner M . Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007; 69(18):1789-99. PMC: 4472366. DOI: 10.1212/01.WNL.0000287431.88658.8b. View

17.

Ellis R, Gamst A, Capparelli E, Spector S, Hsia K, Wolfson T . Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology. 2000; 54(4):927-36. DOI: 10.1212/wnl.54.4.927. View

18.

Gisslen M, Hagberg L, Brew B, Cinque P, Price R, Rosengren L . Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex. J Infect Dis. 2007; 195(12):1774-8. DOI: 10.1086/518043. View

19.

Mellgren A, Price R, Hagberg L, Rosengren L, Brew B, Gisslen M . Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection. Neurology. 2007; 69(15):1536-41. DOI: 10.1212/01.wnl.0000277635.05973.55. View

20.

Gisslen M, Hagberg L, Rosengren L, Brew B, Cinque P, Spudich S . Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers. J Neuroimmune Pharmacol. 2007; 2(1):112-9. DOI: 10.1007/s11481-006-9035-1. View